Chris Froome was cleared of any wrongdoing Tensions between the World Anti-Doping Agency (Wada) and cycling’s governing body over the controversial closure of the investigation into four-time Tour de France winner Chris Froome’s use of salbutamol in 2018 have been revealed.
In correspondence days later, now obtained by BBC Sport, the UCI president David Lappartient told Wada’s then-president Sir Craig Reedie that the agency "appears to be placing full responsibility for the decision squarely on the UCI’s shoulders".
"We both know very well who took the initiative of closing this case and the reasons why," Lappartient continued in the letter.
"It is disappointing to see that your organisation is not taking responsibility on the ground that technically the decision had to be taken by the UCI."
Lappartient also suggested the UCI had "concerns" about Wada’s rules regarding the use of salbutamol, but did not reveal them to Froome because of "an understanding [Wada] would then support the UCI in justifying what, to the public, is a very difficult decision to understand".
When approached by the BBC, the UCI said the letter was part of an exchange of correspondence between the two men "aimed at addressing the relationship" between the two organisations.
Wada said the correspondence was in "the context of a frank discussion… intended to address all outstanding issues openly and honestly… after a period of uncertainty."It said it had "followed all due legal and scientific process".Lawyers for Froome said their client "was never charged with any wrongdoing and was fully exonerated", adding: "The process […]